VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹318 Cr | ₹215 Cr | ₹170 Cr | ₹142 Cr | ₹116 Cr |
What is the latest Profit & Loss Account Balance ratio of VENUS REMEDIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹318 Cr |
| Mar2025 | ₹215 Cr |
| Mar2024 | ₹170 Cr |
| Mar2023 | ₹142 Cr |
| Mar2022 | ₹116 Cr |
How is Profit & Loss Account Balance of VENUS REMEDIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹318 Cr | 47.80 | |
| Mar2025 | ₹215 Cr | 26.31 | |
| Mar2024 | ₹170 Cr | 19.91 | |
| Mar2023 | ₹142 Cr | 22.50 | |
| Mar2022 | ₹116 Cr | - | |
Compare Profit & Loss Account Balance of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,127.7 Cr | -8.7% | -2.6% | 251.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -8.7% |
-2.6% |
251.1% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses